Blood lipid profile in patients with coronary artery disease and sarcopenia

Objective of the study was to investigate the characteristics of lipid metabolism in male patients with coronary artery disease (CAD) depending on the state of muscle mass, strength and function. Material and methods. The investigation enrolled 79 male patients with a reliable diagnosis of CAD, v...

Full description

Bibliographic Details
Main Authors: I. I. Grigorieva, T. A. Raskina, K. E. Krivoshapova, O. S. Malyshenko, M. V. Letaeva, V. L. Masenko, O. L. Barbarash
Format: Article
Language:Russian
Published: Siberian Branch of Russian Academy of Sciences, Research Institute of Internal and Preventive Medicine, branch of the Institute of Cytology and Genetics 2020-09-01
Series:Атеросклероз
Subjects:
Online Access:https://ateroskleroz.elpub.ru/jour/article/view/384/367
_version_ 1797970867906412544
author I. I. Grigorieva
T. A. Raskina
K. E. Krivoshapova
O. S. Malyshenko
M. V. Letaeva
V. L. Masenko
O. L. Barbarash
author_facet I. I. Grigorieva
T. A. Raskina
K. E. Krivoshapova
O. S. Malyshenko
M. V. Letaeva
V. L. Masenko
O. L. Barbarash
author_sort I. I. Grigorieva
collection DOAJ
description Objective of the study was to investigate the characteristics of lipid metabolism in male patients with coronary artery disease (CAD) depending on the state of muscle mass, strength and function. Material and methods. The investigation enrolled 79 male patients with a reliable diagnosis of CAD, verified by coronary angiography (median age 63 (57; 66) years). Diagnosis of sarcopenia was based on the recommendations of the European Working Group on Sarcopenia in Older People (EWGSOP, 2010) with the examining of muscle strength, muscle mass and muscle function. Total cholesterol, triglycerides (TG), high-density lipoproteins (HDL) and low-density lipoproteins (LDL) content was determined in fasting blood serum by spectrophotometric method. Patients were divided into 3 groups (according to the definition of EWGSOP, 2010): 1st–31 patients without sarcopenia, 2nd–21 patients with presarcopenia, and 3rd–27 patients with sarcopenia. Results and discussion. There was an inverse correlation between the level of total cholesterol in patients and the musculoskeletal index (r = –0.315; p = 0.005) and the total skeletal muscle area at level LIII (r = –0.277; p = 0.013). Comparative analysis in the group of patients with coronary artery disease and sarcopenia showed significant higher levels of total cholesterol compared with those in patients with coronary artery disease without sarcopenia (5.20 (3.75; 6.00) mmol/l vs 3.90 (3.40; 4.60) mmol/l; p = 0.03). According to the results of regression analysis, a direct relationship was found between the value of total cholesterol and the risk of decreasing of the musculoskeletal index (odds ratio 1.914, 95 % confidence interval 1.166– 3.141). The receiver operating characteristic (ROC) curve analysis provided the critical value of total cholesterol as 4.7 mmol/l. Conclusion. The presence of sarcopenia in patients with CAD was associated with severe proatherogenic disorders of the lipid profile of the blood. Hypercholesterolemia is an additional predictive factor in reducing muscle mass.
first_indexed 2024-04-11T03:23:47Z
format Article
id doaj.art-8e515e44712f45d78caf635a6b53ec02
institution Directory Open Access Journal
issn 2078-256X
language Russian
last_indexed 2024-04-11T03:23:47Z
publishDate 2020-09-01
publisher Siberian Branch of Russian Academy of Sciences, Research Institute of Internal and Preventive Medicine, branch of the Institute of Cytology and Genetics
record_format Article
series Атеросклероз
spelling doaj.art-8e515e44712f45d78caf635a6b53ec022023-01-02T08:08:47ZrusSiberian Branch of Russian Academy of Sciences, Research Institute of Internal and Preventive Medicine, branch of the Institute of Cytology and GeneticsАтеросклероз2078-256X2020-09-011632330https://doi.org/10.15372/ATER20200303Blood lipid profile in patients with coronary artery disease and sarcopeniaI. I. Grigorieva0https://orcid.org/0000-0003-2855-4358T. A. Raskina1https://orcid.org/0000-0002-5804-4298K. E. Krivoshapova2https://orcid.org/0000-0003-2384-5682O. S. Malyshenko3https://orcid.org/0000-0001-8272-3736M. V. Letaeva4https://orcid.org/0000-0003-3907-7120V. L. Masenko5https://orcid.org/0000-0003-3970-4294O. L. Barbarash6https://orcid.org/0000-0002-4642-3610Kemerovo State Medical University of Minzdrav of Russia Russian FederationKemerovo State Medical University of Minzdrav of Russia Russian FederationResearch Institute for Complex Issues of Cardiovascular Diseases Russian FederationKemerovo State Medical University of Minzdrav of Russia Russian FederationKemerovo State Medical University of Minzdrav of Russia Russian FederationResearch Institute for Complex Issues of Cardiovascular Diseases Russian FederationResearch Institute for Complex Issues of Cardiovascular Diseases Russian FederationObjective of the study was to investigate the characteristics of lipid metabolism in male patients with coronary artery disease (CAD) depending on the state of muscle mass, strength and function. Material and methods. The investigation enrolled 79 male patients with a reliable diagnosis of CAD, verified by coronary angiography (median age 63 (57; 66) years). Diagnosis of sarcopenia was based on the recommendations of the European Working Group on Sarcopenia in Older People (EWGSOP, 2010) with the examining of muscle strength, muscle mass and muscle function. Total cholesterol, triglycerides (TG), high-density lipoproteins (HDL) and low-density lipoproteins (LDL) content was determined in fasting blood serum by spectrophotometric method. Patients were divided into 3 groups (according to the definition of EWGSOP, 2010): 1st–31 patients without sarcopenia, 2nd–21 patients with presarcopenia, and 3rd–27 patients with sarcopenia. Results and discussion. There was an inverse correlation between the level of total cholesterol in patients and the musculoskeletal index (r = –0.315; p = 0.005) and the total skeletal muscle area at level LIII (r = –0.277; p = 0.013). Comparative analysis in the group of patients with coronary artery disease and sarcopenia showed significant higher levels of total cholesterol compared with those in patients with coronary artery disease without sarcopenia (5.20 (3.75; 6.00) mmol/l vs 3.90 (3.40; 4.60) mmol/l; p = 0.03). According to the results of regression analysis, a direct relationship was found between the value of total cholesterol and the risk of decreasing of the musculoskeletal index (odds ratio 1.914, 95 % confidence interval 1.166– 3.141). The receiver operating characteristic (ROC) curve analysis provided the critical value of total cholesterol as 4.7 mmol/l. Conclusion. The presence of sarcopenia in patients with CAD was associated with severe proatherogenic disorders of the lipid profile of the blood. Hypercholesterolemia is an additional predictive factor in reducing muscle mass.https://ateroskleroz.elpub.ru/jour/article/view/384/367atherosclerosislipidssarcopeniacoronary artery disease
spellingShingle I. I. Grigorieva
T. A. Raskina
K. E. Krivoshapova
O. S. Malyshenko
M. V. Letaeva
V. L. Masenko
O. L. Barbarash
Blood lipid profile in patients with coronary artery disease and sarcopenia
Атеросклероз
atherosclerosis
lipids
sarcopenia
coronary artery disease
title Blood lipid profile in patients with coronary artery disease and sarcopenia
title_full Blood lipid profile in patients with coronary artery disease and sarcopenia
title_fullStr Blood lipid profile in patients with coronary artery disease and sarcopenia
title_full_unstemmed Blood lipid profile in patients with coronary artery disease and sarcopenia
title_short Blood lipid profile in patients with coronary artery disease and sarcopenia
title_sort blood lipid profile in patients with coronary artery disease and sarcopenia
topic atherosclerosis
lipids
sarcopenia
coronary artery disease
url https://ateroskleroz.elpub.ru/jour/article/view/384/367
work_keys_str_mv AT iigrigorieva bloodlipidprofileinpatientswithcoronaryarterydiseaseandsarcopenia
AT taraskina bloodlipidprofileinpatientswithcoronaryarterydiseaseandsarcopenia
AT kekrivoshapova bloodlipidprofileinpatientswithcoronaryarterydiseaseandsarcopenia
AT osmalyshenko bloodlipidprofileinpatientswithcoronaryarterydiseaseandsarcopenia
AT mvletaeva bloodlipidprofileinpatientswithcoronaryarterydiseaseandsarcopenia
AT vlmasenko bloodlipidprofileinpatientswithcoronaryarterydiseaseandsarcopenia
AT olbarbarash bloodlipidprofileinpatientswithcoronaryarterydiseaseandsarcopenia